ROLE OF CASPASE-2 IN OSTEOCOLAST APOPTOSIS AGE-EePENDENT OSTEOPOROSIS
CASPASE-2 在破骨细胞凋亡中的作用年龄相关性骨质疏松症
基本信息
- 批准号:7233105
- 负责人:
- 金额:$ 26.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-12-01 至 2011-11-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAgingAnimalsAntioxidantsApoptosisBiochemical ReactionBone ResorptionCalcium/calmodulin-dependent protein kinaseCalmodulinCaspaseCessation of lifeDataDiseaseDown-RegulationElderlyEndopeptidasesFundingKnockout MiceLifeLightMediatingMediator of activation proteinMitochondriaMusNADPNumbersOrganOsteoblastsOsteoclastsOsteogenesisOsteoporosisOxidantsOxidative StressPeptide HydrolasesPhosphotransferasesPlayRateRegulationRoleSkeletonTestingUrineWild Type Mousebasebonebone losscaspase-2in vivooxidationpreventpro-caspase-2
项目摘要
Bone is a living organ that is maintained through continuous formation of new bone by osteoblasts and
resorption of exiting bone by osteoclasts. Loss of bone mass at advanced ages causes osteoporosis.
Caspase-2 is a protease that is involved in programmed cell death (apoptosis). During the last funding
period, we found that caspase-2 is an important regulator of bone mass in aging animals. Our critical
observation was that aging-associated bone loss in old (24-26 month) caspase-2 null mice was more severe
than that in the same age wild type mice. The objective of this proposal is to further study the role of
caspase-2 in aging skeleton. Our hypothesis is that caspase-2 mediates mitochondrial-dependent apoptosis
of aging osteoclasts, which is induced by oxidative stress in vivo. Lack of caspase-2 activity results in
reduced apoptosis of aging osteoclasts, leading to increased bone resorption. To test this hypothesis, first,
we will compare the rate of bone formation and bone resorption in old caspase-2 null and wild type mice to
show that caspase-2 affects bone resorption. Next, we will compare the apoptosis rate in aging osteoclasts
that have increased/decreased antioxidant capacity to show that oxidative stress is a cause of spontaneous
apoptosis of aging osteoclasts. Then, we will compare the apoptosis rate of caspase-2 (-/-)and (+/+) aging
osteoclasts to show that caspase-2 plays an important role in the spontaneous apoptosis of aging
osteoclasts. Finally, we will compare the apoptosis rate in aging osteoclasts that have both altered
antioxidant activity and caspase-2 activity to show that caspase-2 is a mediator of oxidative stress-induced
apoptosis. Calmodulin (CaM) dependent kinase II (CaMK II) can phosphorylate procaspase-2 and prevent
its activation. NADPH, which provides reducing equivalent for various biochemical reactions to scavenge
oxidants, also inhibits the activation of procaspase-2 by enhancing CaMK II function. Based on these
findings, we will test the hypothesis that oxidative stress activates caspase-2 in aging osteoclasts through
down-regulation of NADPH/CaMK II activity by examining the level of NAPDH and oxidation of CaM and
CaMK II. Osteoporosis is a serious disease that affects the elderly. The main strategy and mechanism of
action of current anti-osteoporosis therapy is to induce osteoclast apoptosis. Therefore, this study will shed
the light on the mechanism of apoptosis in osteoclasts and open new avenues for new anti-osteoporosis
therapies.
骨是通过成骨细胞持续形成新骨来维持的活器官,
通过破骨细胞吸收排出的骨。老年骨质流失会导致骨质疏松症。
胱天蛋白酶-2是参与程序性细胞死亡(凋亡)的蛋白酶。在最后一次融资中
期间,我们发现caspase-2是衰老动物骨量的重要调节因子。我们的关键
观察到老年(24-26个月)胱天蛋白酶-2缺失小鼠中与衰老相关的骨丢失更严重
与同龄野生型小鼠相比。这项建议的目的是进一步研究
caspase-2在衰老骨骼中的作用。我们的假设是caspase-2介导了细胞凋亡
老化破骨细胞,这是由体内氧化应激诱导的。缺乏半胱天冬酶-2活性导致
减少老化破骨细胞的凋亡,导致骨吸收增加。为了验证这个假设,首先,
我们将比较老年胱天蛋白酶-2缺失小鼠和野生型小鼠的骨形成和骨吸收速率,
显示胱天蛋白酶-2影响骨吸收。接下来,我们将比较老化破骨细胞的凋亡率
具有增加/降低的抗氧化能力,以表明氧化应激是自发性的
衰老破骨细胞的凋亡。然后,我们将比较caspase-2(-/-)和(+/+)衰老的凋亡率
破骨细胞,以显示caspase-2在衰老的自发性细胞凋亡中起重要作用
破骨细胞最后,我们将比较老化破骨细胞的凋亡率,
抗氧化活性和半胱天冬酶-2活性,以表明半胱天冬酶-2是氧化应激诱导的
凋亡钙调素依赖性激酶II(CaMK II)可磷酸化半胱氨酸天冬氨酸蛋白酶原-2,
其激活。NADPH,它为各种生化反应提供还原当量,
氧化剂,也通过增强CaMK II功能抑制半胱天冬酶原-2的活化。基于这些
研究结果,我们将测试假设,氧化应激激活caspase-2在老化破骨细胞,通过
通过检测NAPDH水平和CaM氧化下调NADPH/CaMK II活性,
CaMK II.骨质疏松症是影响老年人的一种严重疾病。的主要策略和机制
目前抗骨质疏松治疗的作用是诱导破骨细胞凋亡。因此,本研究将
阐明破骨细胞凋亡的机制,为新的抗骨质疏松药物开辟新的途径
治疗
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRIAN A. HERMAN其他文献
BRIAN A. HERMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRIAN A. HERMAN', 18)}}的其他基金
The Mitochondrial Permeabilty Transition in Apoptosis
细胞凋亡中的线粒体通透性转变
- 批准号:
6763185 - 财政年份:2001
- 资助金额:
$ 26.94万 - 项目类别:
The Mitochondrial Permeabilty Transition in Apoptosis
细胞凋亡中的线粒体通透性转变
- 批准号:
6607261 - 财政年份:2001
- 资助金额:
$ 26.94万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 26.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 26.94万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 26.94万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 26.94万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 26.94万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 26.94万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 26.94万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 26.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 26.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 26.94万 - 项目类别:
Operating Grants